Stay updated on GS030 Dose-escalation Safety in Retinitis Pigmentosa Clinical Trial

Sign up to get notified when there's something new on the GS030 Dose-escalation Safety in Retinitis Pigmentosa Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the GS030 Dose-escalation Safety in Retinitis Pigmentosa Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The footer revision identifier changes from v3.7.0 to v3.7.1 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-13T04:22:29.000Z thumbnail image
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    Change Detected
    Summary
    A 403 Forbidden error page is now displayed, replacing the prior study record content. The page also adds a Home link and revision note while removing extensive study details and related terms.
    Difference
    18%
    Check dated 2026-09-21T22:24:22.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    No textual changes were detected on the page; the study details and related information remain as published. The overall presentation and structure appear unchanged.
    Difference
    0.1%
    Check dated 2026-09-07T20:59:34.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    Revision label updated from v3.6.5 to v3.6.6 on the page, indicating a minor template/system update that does not alter the study data.
    Difference
    0.2%
    Check dated 2026-08-31T18:13:12.000Z thumbnail image
  7. Check
    56 days ago
    Change Detected
    Summary
    Adds a funding note '2017 ( U.S. NIH Grant/Contract )' to the study record, providing context about the study's funding. This contextualizes the source of support for the trial.
    Difference
    0.2%
    Check dated 2026-08-24T21:32:20.000Z thumbnail image
  8. Check
    70 days ago
    Change Detected
    Summary
    Revision: v3.6.5 was added, replacing the previous v3.6.4. This change represents an update to the page's metadata rather than substantive alterations to the study details or participant information.
    Difference
    0.1%
    Check dated 2026-08-10T13:47:14.000Z thumbnail image

Stay in the know with updates to GS030 Dose-escalation Safety in Retinitis Pigmentosa Clinical Trial

Enter your email address, and we'll notify you when there's something new on the GS030 Dose-escalation Safety in Retinitis Pigmentosa Clinical Trial page.